Growth Equity Opportunities Fund IV, LLC SEC EDGAR Filings (CIK 0001644965)

SEC EDGAR filings, ownership reports, and insider transactions for Growth Equity Opportunities Fund IV, LLC.

Business address
1954 Greenspring Drive, Suite 600, Timonium, MD, 21093
Top holdings (Schedule 13D)
VRNA
State of incorporation
DE
Fiscal year end
31 December
Former names
Growth Equity Opportunities IV, LLC (to 21 Dec 2018)
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Growth Equity Opportunities Fund IV, LLC has filed 58 SEC EDGAR filings since 17 Jun 2015

Latest Filings

Recent SEC filings for Growth Equity Opportunities Fund IV, LLC including SCHEDULE 13D/A, SC 13D/A, 4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D/A Open SCHEDULE 13D/A document | Open XBRL data View SEC filing for SCHEDULE 13D/A 21 Jan 2025
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# 28 Aug 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) 14 Aug 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) 05 Aug 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) 08 Dec 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) 10 Apr 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3 28 Nov 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC -- SCHEDULE 13DAE (#6) 01 Nov 2022
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 21 Oct 2022 19 Oct 2022 001-34655
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# 07 Sep 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2 23 Aug 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13DA1 10 Jan 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (AFFIMED N.V.) - SCHEDULE 13D/A(#3) 21 Apr 2021
SC 13D Open SC 13D document View SEC filing for SC 13D GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D 22 Jan 2021
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# 03 Aug 2020
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC -- SCHEDULE 13DA (#5) 24 Jun 2020
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Jun 2020 19 Jun 2020 001-34655
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC - AFFIMED N.V. -- SCHEDULE 13D/A (AMEND 18 Nov 2019
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC - AVEO PHARMACEUTICALS, INC. -- SCHEDUL 17 Apr 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Apr 2019 08 Apr 2019 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 21 Dec 2018 20 Dec 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Dec 2018 11 Dec 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Dec 2018 06 Dec 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Nov 2018 28 Nov 2018 001-34655
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC - AVEO PHARMACEUTICALS, INC. -- SCHEDUL 28 Nov 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 21 Nov 2018 20 Nov 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Nov 2018 15 Nov 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Aug 2018 21 Aug 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 20 Jul 2018 18 Jul 2018 001-34655
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC - AVEO PHARMACEUTICALS, INC. -- SCHEDUL 10 Jul 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Jun 2018 27 Jun 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 May 2018 30 May 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 21 May 2018 17 May 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 May 2018 08 May 2018 001-34655
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Apr 2018 06 Apr 2018 001-34655
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- CASCADIAN THERAPEUTICS, INC. - SCHE 19 Mar 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Mar 2018 09 Mar 2018 001-33882
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- ARCA BIOPHARMA, INC. - SCHEDULE 13D 05 Mar 2018
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- CASCADIAN THERAPEUTICS, INC. - SCHE 02 Mar 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 27 Feb 2018 26 Feb 2018 000-22873
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Feb 2018 20 Feb 2018 001-33882
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV, LLC - AFFIMED N.V. -- SCHEDULE 13D/A - AMEN 22 Feb 2018
SC 13D Open SC 13D document View SEC filing for SC 13D VERONA PHARMA PLC -- SCHEDULE 13D 09 May 2017
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SCHEDULE 13D/A - AMEND. NO. 1 04 Apr 2017
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 29 Mar 2017 28 Mar 2017 001-34655
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A CASCADIAN THERAPEUTICS, INC. - AMEND. NO. 1 06 Feb 2017
SC 13D Open SC 13D document View SEC filing for SC 13D AFFIMED N.V. - SCHEDULE 13D 03 Feb 2017
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 01 Feb 2017 27 Jan 2017 001-33882
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ACHAOGEN, INC. -- AMENDMENT #1 22 Dec 2016
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Dec 2016 19 Dec 2016 001-36323
SC 13D Open SC 13D document View SEC filing for SC 13D CASCADIAN THERAPEUTICS, INC. - 13D 11 Jul 2016
SC 13D Open SC 13D document View SEC filing for SC 13D ACHAOGEN, INC. - 13D 13 Jun 2016
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 07 Jun 2016 03 Jun 2016 001-36323
SC 13D Open SC 13D document View SEC filing for SC 13D AVEO PHARMACEUTICALS, INC. - 13D 31 May 2016
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 17 May 2016 13 May 2016 001-34655
SC 13D Open SC 13D document View SEC filing for SC 13D STRONGBRIDGE BIOPHARMA, INC. 03 Nov 2015
SC 13D Open SC 13D document View SEC filing for SC 13D ARCA BIOPHARMA, INC. 29 Jun 2015
3 Open 3 document View SEC filing for 3 17 Jun 2015 16 Jun 2015 000-22873

About this filer

Growth Equity Opportunities Fund IV, LLC files with the SEC under CIK 0001644965. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages